Efficacy of abatacept and tocilizumab in patients with rheumatoid arthritis treated in clinical practice: results from the nationwide Danish DANBIO registry

Henrik Christian Leffers, Mikkel Østergaard, Bente Glintborg, Niels Steen Krogh, Heidi Foged Henriksen, Ulrik Tarp, Tove Lorenzen, Annette Hansen, Michael Sejer Hansen, Martin Skov Jacobsen, Lene Dreyer, Merete Lund Hetland, all departments of rheumatology in Denmark

114 Citations (Scopus)

Abstract

To describe drug survival, disease activity and clinical response in patients with rheumatoid arthritis (RA) treated with abatacept or tocilizumab in routine care, based on prospectively registered observational data from the nationwide Danish DANBIO registry.
Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Volume70
Issue number7
Pages (from-to)1216-22
Number of pages7
ISSN0003-4967
DOIs
Publication statusPublished - 2011

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Arthritis, Rheumatoid
  • C-Reactive Protein
  • Epidemiologic Methods
  • Female
  • Humans
  • Immunoconjugates
  • Male
  • Medication Adherence
  • Middle Aged
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha
  • Young Adult

Fingerprint

Dive into the research topics of 'Efficacy of abatacept and tocilizumab in patients with rheumatoid arthritis treated in clinical practice: results from the nationwide Danish DANBIO registry'. Together they form a unique fingerprint.

Cite this